Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 40INDUSTRY 24NIH 3FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Recurrence 1Neoplasms 1Neoplasm Metastasis 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

Methods 2Exercise 2Yoga 1Standard of Care 1Simvastatin 1Selective Serotonin Reuptake Inhibitors 1Radiosurgery 1Oxaliplatin 1Nutritional Status 1Methylphenidate 1Hydroxymethylglutaryl-CoA Reductase Inhibitors 1Fluorouracil 1Exercise Therapy 1Docetaxel 1Diet, Ketogenic 1Cystoscopy 1Coping Skills 1Citalopram 1Ambulatory Care Facilities 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Neoplasms × Oxaliplatin × Clear all
NCT00557206 2013-11-05

Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer

Minneapolis Veterans Affairs Medical Center

Phase 2 Terminated
35 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡